ARTICLE | Clinical News
Seneca Valley Virus regulatory update
October 13, 2008 7:00 AM UTC
FDA granted Orphan Drug designation for Neotropix's NTX-010 to treat neuroendocrine cancers. The naturally occurring oncolytic virus is in Phase I testing for the indication. ...